Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-22-Speech-1-166"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20101122.17.1-166"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Madam President, in the European Union, we stand for the principle of consumer, in this case, patient, awareness and are aiming for citizens to partly take responsibility for their own health. However, our duty as politicians is to protect patients from incorrect and misleading information. That is what we are doing today.
As far as public access to information about pharmaceuticals is concerned, it would seem that the situation varies across the European Union. The distinction between information and advertising is becoming less clear. I therefore support Parliament’s position which aims for a clearer definition of information and advertising. It is important for patients to obtain reliable objective information in their mother tongue, for it to be designed for the non-expert public, and for it to be easy to understand and access, bearing in mind the particular needs of consumers. As well as patients, we must protect doctors from hidden advertising as their relationship in the treatment process is particularly important.
We are living in an age when borders are disappearing and information can move freely, just as we can ourselves. Therefore, we must apply certain safeguards to ensure the wellbeing of European patients. I therefore congratulate the rapporteur for his excellent work and hope that we will all be healthier and will have easier access to information."@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples